PF-07259955
/ Pfizer
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
September 10, 2022
A First-in-human Study of Multiple Doses of Topically Administered PF-07295324 and PF-07259955
(clinicaltrials.gov)
- P1 | N=24 | Completed | Sponsor: Pfizer | Active, not recruiting ➔ Completed
Trial completion
August 05, 2022
A First-in-human Study of Multiple Doses of Topically Administered PF-07295324 and PF-07259955
(clinicaltrials.gov)
- P1 | N=24 | Active, not recruiting | Sponsor: Pfizer | Recruiting ➔ Active, not recruiting
Enrollment closed
1 to 2
Of
2
Go to page
1